Fertility Series. Updates on treatments and technology

Recommended reading

  • Díaz-Hernández I, Alecsandru D, García-Velasco JA, Domínguez F.  Uterine natural killer cells: from foe to friend in reproduction. Hum Reprod Update. 2021 Jun 22;27(4):720-746. doi: 10.1093/humupd/dmaa062.
  • Herlihy NS, Klimczak AM, Titus S, Scott C, Hanson BM, Kim JK, et al. The role of endometrial staining for CD138 as a marker of chronic endometritis in predicting live birth.  J Assist Reprod Genet. 2022 Feb; 39(2): 473–479. doi: 10.1007/s10815-021-02374-z.
  • Kennedy KM, de Goffau MC, Perez-Muñoz ME, Arrieta MC, Bäckhed F, Bork P, et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature. 2023 Jan;613(7945):639-649. doi: 10.1038/s41586-022-05546-8.
  • Moffet A, Colucci F. Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Inmunological Reviews. 2015;267(1): 283-297.
  • Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome. 2022 Jan 4;10(1):1. doi: 10.1186/s40168-021-01184-w.
  • Ribeiro VC, Santos-Ribeiro S, De Munck N, Drakopoulos P, Polyzos NP, Schutyser V, et al. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight. Reprod Biomed Online. 2018 Apr;36(4):416-426. doi: 10.1016/j.rbmo.2017.12.016.
  • Xiong Y, Chen Q, Chen C, Tan J, Wang Z, Gu F, Xu Y. Fertil Steril. 2021 Aug;116(2):413-421. doi: 10.1016/j.fertnstert.2021.03.036. 
  • Grynberg M, Cedrin-Durnerin I, Raguideau F, Herquelot E, Luciani L, Porte F, et al. Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS). Best Practice & Research Clinical Obstetrics & Gynaecology. 2023 June; 88.
  • Chua SJ, Mol BW, Longobardi S, Orvieto R, Venetis CA, Lispi M, et al. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis. Reprod Biol Endocrinol 19, 51 (2021). 
  • Bühler KF, Fischer R, Verpillat P, Allignol A, Guedes S, Boutmy E, et al. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany. Reprod Biol Endocrinol 19, 90 (2021). 
  • Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.. Hum Reprod. 2010 Aug;25(8):2092-100. 
  • Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reprod Biomed Online. 2013 Nov;27(5):530-8.
  • Healy MW, Patounakis G, Connell MT, Devine K, DeCherney AH, Levy MJ, Hill MJ. Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? Fertil Steril. 2016 Jan;105(1):93-9.e1. 
  • Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002 Nov;78(5):1025-9. 
  • Martínez F, Clua E, Roca M, Garcia S, Polyzos NP. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles. Human Reproduction. 2022 Nov 24;37(12):2777-2786.  
  • Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997 Mar;67(3):521-6. doi: 10.1016/s0015-0282(97)80080-5.
  • Yousseff M, Abdallah KS. Biosimilar recombinant human fsh (follitropin alpha) for controlled ovarian stimulation in ovulatory women undergone ivf/icsi cycles? A systematic review and meta-análisis. Fertility and Sterility. 2022;118(4):e320.
  • Díaz-García C, Herraiz S, Pamplona L, Subirá J, Soriano MJ, Simon C, Seli E, Pellicer A. Follicular activation in women previously diagnosed with poor ovarian response: a randomized, controlled trial. Fertil Steril. 2022 Apr;117(4):747-755. doi: 10.1016/j.fertnstert.2021.12.034.
  • Kawamura K, Ishizuka B, Hsueh AJW. Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve. Reprod Biomed Online. 2020 Feb;40(2):245-253. doi: 10.1016/j.rbmo.2019.09.007.
  • Pellicer N, Cozzolino M, Diaz-García C, Galliano D, Cobo A, Pellicer A, Herraiz S. Ovarian rescue in women with premature ovarian insufficiency: facts and fiction. Reprod Biomed Online. 2023 Mar;46(3):543-565. doi: 10.1016/j.rbmo.2022.12.011.
  • Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Human Reproduction. 2015;30(3):608-15. doi: 10.1093/humrep/deu353.

For queries and the reporting of incidents, please contact faqs@cmep-fertility.com

Accredited with 3 European CME Credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).